missing translation for 'onlineSavingsMsg'
Learn More

Promega ADP-Glo™ Kinase Assay DFS Item

ADP-Glo™ Kinase Assay is a luminescent kinase assay that measures ADP formed from a kinase reaction; ADP is converted into ATP, which is converted into light by Ultra-Glo™ Luciferase. The luminescent signal positively correlates with kinase activity.

$1379.53 - $39268.43

Spécifications

Content And Storage -30°C to -10°C
voir les spécifications

Comprend: ADP-Glo Reagent, Kinase Detection Buffer, Kinase Detection Substrate, Ultra Pure ATP (10mM), ADP (10mM)

Produits 4
Numéro de catalogue Numéro du manufacturier. Quantity Prix Quantité  
Numéro de catalogue Numéro du manufacturier. Quantity Prix Quantité  
PRV9103 DFS Item
Afficher les documents
Promega
V9103
100,000 Assays N/A
N/A
Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.
PRV9101 DFS Item
Afficher les documents
Promega
V9101
1000 Assays
chaque for $1,379.53
Il en reste null
 
PRV9102 DFS Item
Afficher les documents
Promega
V9102
10,000 Assays
chaque for $7,873.97
Il en reste null
 
PRV9104 DFS Item
Afficher les documents
Promega
V9104
100,000 Assays, Bulk Pack N/A
N/A
Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.
Description

Description

  • One Assay for all your Kinase Screening Needs
  • Use with virtually any kinase
  • Stable luminescent signal
  • Sensitive to low concentrations of ADP
Spécifications

Spécifications

-30°C to -10°C
Videos
FDS
missing translation for 'documents'

missing translation for 'documents'

  • (a)Patents Pending.
  • (b)Australian Pat. No. 2003268489 and other patents pending.
  • (c)U.S. Pat. Nos. 6,602,677 and 7,241,584, Australian Pat. Nos. 754312 and 785294 and other patents and patents pending.
  • (d)The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.
  • (e)Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.